About Bioscan Research
Bioscan Research is a Healthcare company based in Ahmedabad (India) founded in 2013 by Anupam Lavania and Shilpa Malik. AI-powered medical devices for intracranial haemorrhage screening are developed. Bioscan Research has raised $1.03 million across 5 funding rounds from investors including Indian Institute of Technology Kanpur, Bind 4.0 and iCreate. Bioscan Research was last valued at $1.4 million in September 2019. Its chief executive, as recorded, is Anupam Lavania. Its Indian entity Bioscan Research Private Limited reported revenue of ₹13.40 Cr. Bioscan Research offers products and services including CEREBO. Its focus areas include Life Sciences, Neurology, Medical Devices and Screening Devices.
Company details
Bioscan Research was established in 2013 in Ahmedabad, India, within the healthcare sector focused on medical devices and AI applications. Intracranial haemorrhage screening is facilitated through portable tools designed for use at trauma sites, supporting patient triaging and diagnostic processes. Detection of mild traumatic brain injuries is enabled, particularly for asymptomatic or mildly symptomatic cases, to aid early intervention in clinical settings.
- Headquarters Ahmedabad, India
- Founders Anupam Lavania, Shilpa Malik
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bioscanresearch.com
- Social LinkedIn X Facebook YouTube
- Legal Name Bioscan Research Private Limited
- Date of Incorporation 13 Sep, 2017
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹13.40 Cr
FY 2025 · -4% YoY
- Net Profit₹1.06 Cr
FY 2025 · 8% margin
- EBITDA₹1.34 Cr
FY 2025 · 10% margin
- Total Equity Funding$1.03M (USD)
in 5 rounds
- Latest Funding Round$1M (USD), Seed
Jul 2026
- Investors
Associated legal entities of Bioscan Research
Bioscan Research operates through Bioscan Research Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bioscan Research Private Limited CIN U74999GJ2017PTC099067 | Active | 13 Sep 2017 | Ahmedabad, Gujarat | ₹13.4 Cr | 2 | View details |
Products & Services of Bioscan Research
Bioscan Research offers a comprehensive portfolio of products and services, including CEREBO.
Portable tool for non-invasive detection of intracranial hemorrhage in emergencies.
Funding Insights of Bioscan Research
Bioscan Research has successfully raised a total of $1.03M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $1 million completed in July 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.03M
- Total Rounds 5
- Last Round Seed — $1M
- Investors Count 5
All 5 funding rounds of Bioscan Research with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2026 | $1M | Seed | – | Unicorn India Ventures | – |
| Sep 2019 | $31,272 | Seed | $1.4M | Indian Institute of Technology Kanpur | – |
| Jan 2019 | Seed | – | Bind 4.0 | – | |
| Aug 2018 | Seed | – | iCreate | – | |
| Jun 2017 | Debt – Conventional | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Sep 2019 | $1.4M | •••••••• |
Last known valuation $1.4M (Sep 2019). 5 investors in total: 5 institutional.
Investors in Bioscan Research
Bioscan Research has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Indian Institute of Technology Kanpur, Bind 4.0 and iCreate.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government-backed accelerator program is provided for startups in Spain. | bind40.com | Vitoria Gasteiz, Spain | ||
Startups in diverse technologies are incubated over two years. | icreate.org.in | Ahmedabad, India | ||
Venture capital firm investing in applied generative AI | capria.vc | Seattle, United States | ||
| unicornivc.com | ||||
Multiple engineering courses and degrees are offered at the institute. | 1959 | iitk.ac.in | Kanpur, India |
Investor details for Bioscan Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Bioscan Research Private Limited (Bioscan Research)
Bioscan Research Private Limited is the primary company behind Bioscan Research. The board of Bioscan Research Private Limited currently have 2 directors; the longest-serving is Shilpa Malik, appointed in 2017.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shilpa Malik DIN 06461825 | Director | 13 Sep 2017 | 9 yrs 1 mo | Bioscan Research Private Limited |
| Anupam Lavania DIN 06461817 | Director | 13 Sep 2017 | 9 yrs 1 mo | Bioscan Research Private Limited |
People of Bioscan Research
2 people are tracked at Bioscan Research (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership | |
| Co-Founder & CTO | Leadership |
Complete people profiles for Bioscan Research
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Bioscan Research
Figures of Bioscan Research Private Limited, the primary company behind Bioscan Research, for FY 2025. Revenue was ₹13.40 Cr (-4% year on year). Net profit was ₹1.06 Cr (8% margin). EBITDA was ₹1.34 Cr (10% margin). Revenue has grown at a compounded annual rate of +185% over three years and +101% over five years.
- ₹13.40 CrRevenue · FY 2025 · -4% YoY
- ₹1.06 CrNet profit · 8% margin
- ₹1.34 CrEBITDA · 10% margin
- ₹25 LakhPaid-up capital
- +185%Revenue CAGR, 3 years
- +101%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Bioscan Research Private Limited are on its company page.
Detailed financial statements for Bioscan Research
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Bioscan Research
4 dated milestones of Bioscan Research across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Bioscan Research is founded.
- Funding First funding round.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $1.0M.
Web traffic of Bioscan Research
The website of Bioscan Research (bioscanresearch.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 25.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bioscan Research
Complete news archive for Bioscan Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioscan Research
Bioscan Research was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Bioscan Research is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Anupam Lavania is the CEO of Bioscan Research, as recorded in our data. They have also founded this company.
Bioscan Research is a funded company, having raised a total of $1.03M across 5 funding rounds to date.
The primary company behind Bioscan Research, Bioscan Research Private Limited, reported revenue of ₹13.40 Cr for FY 2025, down 4% year on year.
Bioscan Research was established in 2013 in Ahmedabad, India, within the healthcare sector focused on medical devices and AI applications. Intracranial haemorrhage screening is facilitated through portable tools designed for use at trauma sites, supporting patient triaging and diagnostic processes. Detection of mild traumatic brain injuries is enabled, particularly for asymptomatic or mildly symptomatic cases, to aid early intervention in clinical settings.
Bioscan Research offers CEREBO.
Bioscan Research has 5 investors. Key investors include Indian Institute of Technology Kanpur, Bind 4.0, iCreate, Capria, and Unicorn India Ventures.
The valuation of Bioscan Research is $1.4M as of Sep 2019.
Bioscan Research operates through Bioscan Research Private Limited.
The legal entities of Bioscan Research currently have 2 directors, including Shilpa Malik, Anupam Lavania.